Trial intelligence / Profile preview

Vitamin K1 and aloe vera cream for chemotherapy-induced dermatologic side effects

IRCT20240713062423N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jul 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of phytomenadione and aloe vera in metastatic colorectal adenocarcinoma (mCRC), acneiform rash and dermatologic toxicity, sponsored by Tehran University of Medical Sciences. Started Jul 2025; status: completed.

02

Drugs

phytomenadionealoe vera
03

Conditions

metastatic colorectal adenocarcinoma (mCRC)acneiform rashdermatologic toxicity

Beyond the preview

Go deeper on IRCT20240713062423N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240713062423N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call